SCRS Launches Eagle Insights Dashboard To Score Sponsor And CRO Site Relationships

The Society for Clinical Research Sites has launched the Eagle Insights Dashboard, a data intelligence platform aimed at measuring how sponsors and CROs perform in their relationships with clinical trial sites.

According to an Oct. 15 release, the platform gives sponsors and CROs a score built from site ratings across categories that SCRS says matter most to trial success. Those categories include study start-up and planning, business development, contract language, communication and advocacy, representative patient populations, and technology.

What the dashboard measures

The stated pitch is less about adding another trial metric than about making site feedback comparable and actionable. SCRS said sponsors and CROs can use the data to identify engagement gaps early, benchmark their performance against peers, and make more informed investment and process decisions.

Jimmy Bechtel, chief site success officer at SCRS, said in the release that many sponsors and CROs say they want to be a partner of choice for sites, but few have had a reliable way to measure whether that is true. He said the dashboard shows where site relationships are working, where they are not, and how an organization compares with peers and competitors.

Why it matters operationally

Site relationships are often discussed as a qualitative part of trial execution, so SCRS is trying to convert that into a standardized signal that procurement and operations teams can track over time. If the scoring proves credible with buyers, the commercial value is not the dashboard alone but the possibility that sponsor-site behavior becomes a measurable procurement criterion rather than an anecdotal complaint.

SCRS said that by November the dashboard will include data from 2025 and 2026, enabling organizations to analyze trends and performance over time. The group also said a leading global biopharmaceutical company has already adopted the tool as part of its effort to strengthen site relationships.

That early adoption claim does not establish broad market uptake, but it suggests sponsors may be willing to treat site sentiment as an operational dataset rather than a soft relationship issue.